Biofabrication and Monitoring of a 3D Printed Skin Model for Melanoma
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Paula Vázquez-Aristizabal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cells and Aging Group, Biogipuzkoa Health Research Institute, Paseo Dr. Begiristain s/n, Donostia-San Sebastián, 20014, Spain. Hauptthemen laut MEDLINE: Melanoma, Printing, Three-Dimensional. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, European Union, Ekonomiaren Garapen eta Lehiakortasun Saila, Eusko Jaurlaritza.
Abstract (Originalsprache)
There is an unmet need for in vitro cancer models that emulate the complexity of human tissues. 3D‐printed solid tumor micromodels based on decellularized extracellular matrices (dECMs) recreate the biomolecule‐rich matrix of native tissue. Herein a 3D in vitro metastatic melanoma model that is amenable for drug screening purposes and recapitulates features of both the tumor and the skin microenvironment is described. Epidermal, basement membrane, and dermal biocompatible inks are prepared by means of combined chemical, mechanical, and enzymatic processes. Bioink printability is confirmed by rheological assessment and bioprinting, and bioinks are subsequently combined with melanoma cells and dermal fibroblasts to build complex 3D melanoma models. Cells are tracked by confocal microscopy and surface‐enhanced Raman spectroscopy (SERS) mapping. Printed dECMs and cell tracking allow modeling of the initial steps of metastatic disease, and may be used to better understand melanoma cell behavior and response to drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stem Cells and Aging Group, Biogipuzkoa Health Research Institute, Paseo Dr. Begiristain s/n, Donostia-San Sebastián, 20014, Spain.
- CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, Donostia-San Sebastián, 20014, Spain.
- Centro de Investigación Biomédica en Red, Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Donostia-San Sebastián, 20014, Spain.
- Ikerbasque Basque Foundation for Science, Bilbao, 48009, Spain.
- Obstetrics and Gynaecology Service, Donostia University Hospital, Paseo Dr. Begiristain s/n, Donostia-San Sebastián, 20014, Spain.
- Department of Chemical Sciences, University of Padova, Via Marzolo, 1, Padova, 35131, Italy.
ORCID-Profile: Paula Vázquez-Aristizabal, Malou Henriksen-Lacey, Clara García-Astrain, Dorleta Jimenez de Aberasturi, Luis M Liz-Marzán, Ander Izeta
Förderung
- Instituto de Salud Carlos III
- European Union
- Ekonomiaren Garapen eta Lehiakortasun Saila, Eusko Jaurlaritza
- Osasun Saila, Eusko Jaurlaritzako
- Diputación Foral de Gipuzkoa
- Agencia Estatal de Investigación
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
- European Research Council
Zitieren
APA
Vázquez-Aristizabal, P., Henriksen-Lacey, M., García-Astrain, C., Jimenez de Aberasturi, D., Langer, J., Epelde, C., Litti, L., Liz-Marzán, L. M., & Izeta, A. (2024). Biofabrication and Monitoring of a 3D Printed Skin Model for Melanoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401136
Vancouver
Vázquez-Aristizabal P, Henriksen-Lacey M, García-Astrain C, Jimenez de Aberasturi D, Langer J, Epelde C, et al. Biofabrication and Monitoring of a 3D Printed Skin Model for Melanoma. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401136
BibTeX
@article{VzquezAristizabal2024,
author = {Vázquez-Aristizabal, Paula and Henriksen-Lacey, Malou and García-Astrain, Clara and Jimenez de Aberasturi, Dorleta and Langer, Judith and Epelde, Claudia and Litti, Lucio and Liz-Marzán, Luis M and Izeta, Ander},
title = {Biofabrication and Monitoring of a 3D Printed Skin Model for Melanoma},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401136}
}
EUVIMED